nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ABCB1—Parkinson's disease	0.519	1	CbGaD
Lapatinib—ERBB2—embryo—Parkinson's disease	0.00599	0.0384	CbGeAlD
Lapatinib—ERBB4—embryo—Parkinson's disease	0.00599	0.0384	CbGeAlD
Lapatinib—ERBB4—brainstem—Parkinson's disease	0.00549	0.0352	CbGeAlD
Lapatinib—ERBB4—forebrain—Parkinson's disease	0.0053	0.0339	CbGeAlD
Lapatinib—TAP1—medulla oblongata—Parkinson's disease	0.00524	0.0336	CbGeAlD
Lapatinib—PIK3C2B—medulla oblongata—Parkinson's disease	0.00492	0.0315	CbGeAlD
Lapatinib—TAP1—midbrain—Parkinson's disease	0.00479	0.0307	CbGeAlD
Lapatinib—TAP1—spinal cord—Parkinson's disease	0.00467	0.0299	CbGeAlD
Lapatinib—PIK3C2B—midbrain—Parkinson's disease	0.0045	0.0288	CbGeAlD
Lapatinib—ERBB2—cardiovascular system—Parkinson's disease	0.00448	0.0287	CbGeAlD
Lapatinib—ERBB4—cardiovascular system—Parkinson's disease	0.00448	0.0287	CbGeAlD
Lapatinib—PIK3C2B—spinal cord—Parkinson's disease	0.00439	0.0281	CbGeAlD
Lapatinib—PIK3C2B—head—Parkinson's disease	0.0039	0.025	CbGeAlD
Lapatinib—ERBB4—medulla oblongata—Parkinson's disease	0.00383	0.0245	CbGeAlD
Lapatinib—TAP1—cerebellum—Parkinson's disease	0.0037	0.0237	CbGeAlD
Lapatinib—PIK3C2B—nervous system—Parkinson's disease	0.0037	0.0237	CbGeAlD
Lapatinib—PI4KB—medulla oblongata—Parkinson's disease	0.00358	0.023	CbGeAlD
Lapatinib—PIK3C2B—central nervous system—Parkinson's disease	0.00356	0.0228	CbGeAlD
Lapatinib—ERBB4—midbrain—Parkinson's disease	0.0035	0.0224	CbGeAlD
Lapatinib—PIK3C2B—cerebellum—Parkinson's disease	0.00348	0.0223	CbGeAlD
Lapatinib—ERBB4—spinal cord—Parkinson's disease	0.00341	0.0219	CbGeAlD
Lapatinib—PI4KB—midbrain—Parkinson's disease	0.00328	0.021	CbGeAlD
Lapatinib—PI4KB—spinal cord—Parkinson's disease	0.0032	0.0205	CbGeAlD
Lapatinib—ERBB2—head—Parkinson's disease	0.00303	0.0194	CbGeAlD
Lapatinib—ERBB4—head—Parkinson's disease	0.00303	0.0194	CbGeAlD
Lapatinib—TAP1—brain—Parkinson's disease	0.00301	0.0193	CbGeAlD
Lapatinib—ERBB4—nervous system—Parkinson's disease	0.00287	0.0184	CbGeAlD
Lapatinib—ERBB2—nervous system—Parkinson's disease	0.00287	0.0184	CbGeAlD
Lapatinib—PI4KB—head—Parkinson's disease	0.00284	0.0182	CbGeAlD
Lapatinib—PIK3C2B—brain—Parkinson's disease	0.00283	0.0181	CbGeAlD
Lapatinib—ERBB2—central nervous system—Parkinson's disease	0.00277	0.0177	CbGeAlD
Lapatinib—ERBB4—central nervous system—Parkinson's disease	0.00277	0.0177	CbGeAlD
Lapatinib—ERBB2—cerebellum—Parkinson's disease	0.00271	0.0173	CbGeAlD
Lapatinib—ERBB4—cerebellum—Parkinson's disease	0.00271	0.0173	CbGeAlD
Lapatinib—PI4KB—nervous system—Parkinson's disease	0.00269	0.0173	CbGeAlD
Lapatinib—PI4KB—central nervous system—Parkinson's disease	0.00259	0.0166	CbGeAlD
Lapatinib—PI4KB—cerebellum—Parkinson's disease	0.00253	0.0162	CbGeAlD
Lapatinib—EGFR—cerebellum—Parkinson's disease	0.00229	0.0147	CbGeAlD
Lapatinib—ERBB2—brain—Parkinson's disease	0.0022	0.0141	CbGeAlD
Lapatinib—ERBB4—brain—Parkinson's disease	0.0022	0.0141	CbGeAlD
Lapatinib—PI4KB—brain—Parkinson's disease	0.00206	0.0132	CbGeAlD
Lapatinib—EGFR—brain—Parkinson's disease	0.00186	0.0119	CbGeAlD
Lapatinib—Gefitinib—CYP2D6—Parkinson's disease	0.00127	0.583	CrCbGaD
Lapatinib—Gefitinib—ABCB1—Parkinson's disease	0.000904	0.417	CrCbGaD
Lapatinib—ABCB1—embryo—Parkinson's disease	0.00078	0.005	CbGeAlD
Lapatinib—ABCB1—forebrain—Parkinson's disease	0.00069	0.00442	CbGeAlD
Lapatinib—CYP2C8—brain—Parkinson's disease	0.000597	0.00383	CbGeAlD
Lapatinib—ABCB1—cardiovascular system—Parkinson's disease	0.000583	0.00374	CbGeAlD
Lapatinib—CYP3A4—nervous system—Parkinson's disease	0.000529	0.00339	CbGeAlD
Lapatinib—CYP3A4—central nervous system—Parkinson's disease	0.000509	0.00326	CbGeAlD
Lapatinib—ABCB1—medulla oblongata—Parkinson's disease	0.000498	0.00319	CbGeAlD
Lapatinib—ABCB1—midbrain—Parkinson's disease	0.000456	0.00292	CbGeAlD
Lapatinib—ABCB1—spinal cord—Parkinson's disease	0.000444	0.00285	CbGeAlD
Lapatinib—ABCB1—head—Parkinson's disease	0.000395	0.00253	CbGeAlD
Lapatinib—ABCB1—nervous system—Parkinson's disease	0.000375	0.0024	CbGeAlD
Lapatinib—ABCB1—central nervous system—Parkinson's disease	0.000361	0.00231	CbGeAlD
Lapatinib—ABCB1—cerebellum—Parkinson's disease	0.000352	0.00226	CbGeAlD
Lapatinib—ABCB1—brain—Parkinson's disease	0.000286	0.00183	CbGeAlD
Lapatinib—EGFR—Signaling by GPCR—DRD1—Parkinson's disease	6.28e-05	0.000195	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—CASP3—Parkinson's disease	6.26e-05	0.000194	CbGpPWpGaD
Lapatinib—ERBB2—Disease—APOE—Parkinson's disease	6.25e-05	0.000194	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TALDO1—Parkinson's disease	6.2e-05	0.000192	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—OMD—Parkinson's disease	6.2e-05	0.000192	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—IL6—Parkinson's disease	6.19e-05	0.000192	CbGpPWpGaD
Lapatinib—ERBB4—Disease—APOE—Parkinson's disease	6.16e-05	0.000191	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PENK—Parkinson's disease	6.12e-05	0.00019	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAG—Parkinson's disease	6.12e-05	0.00019	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—COMT—Parkinson's disease	6.11e-05	0.00019	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—IL6—Parkinson's disease	6.1e-05	0.000189	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—Parkinson's disease	6.09e-05	0.000189	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	6.08e-05	0.000189	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—DRD3—Parkinson's disease	6.08e-05	0.000189	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	6.07e-05	0.000188	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—OMD—Parkinson's disease	6.05e-05	0.000188	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TALDO1—Parkinson's disease	6.05e-05	0.000188	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	6.03e-05	0.000187	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	6e-05	0.000186	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.98e-05	0.000186	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	5.88e-05	0.000182	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—IL6—Parkinson's disease	5.82e-05	0.000181	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—IL6—Parkinson's disease	5.79e-05	0.00018	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—Parkinson's disease	5.77e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—MAPK8—Parkinson's disease	5.76e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—Parkinson's disease	5.74e-05	0.000178	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NDUFB11—Parkinson's disease	5.74e-05	0.000178	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—ADRBK1—Parkinson's disease	5.68e-05	0.000176	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.66e-05	0.000176	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF2—Parkinson's disease	5.63e-05	0.000175	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GCH1—Parkinson's disease	5.61e-05	0.000174	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PDYN—Parkinson's disease	5.6e-05	0.000174	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GBA—Parkinson's disease	5.6e-05	0.000174	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—FBP1—Parkinson's disease	5.6e-05	0.000174	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—DBH—Parkinson's disease	5.6e-05	0.000174	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.59e-05	0.000174	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF2—Parkinson's disease	5.55e-05	0.000172	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.51e-05	0.000171	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—DRD2—Parkinson's disease	5.5e-05	0.000171	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR7—Parkinson's disease	5.5e-05	0.000171	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GCH1—Parkinson's disease	5.47e-05	0.00017	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF1R—Parkinson's disease	5.45e-05	0.000169	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—INS—Parkinson's disease	5.43e-05	0.000169	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	5.4e-05	0.000168	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—Parkinson's disease	5.4e-05	0.000168	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—Parkinson's disease	5.4e-05	0.000168	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EDN1—Parkinson's disease	5.38e-05	0.000167	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF1R—Parkinson's disease	5.36e-05	0.000166	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—Parkinson's disease	5.35e-05	0.000166	CbGpPWpGaD
Lapatinib—ERBB2—Disease—INS—Parkinson's disease	5.34e-05	0.000166	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—Parkinson's disease	5.3e-05	0.000165	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EDN1—Parkinson's disease	5.3e-05	0.000165	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—Parkinson's disease	5.28e-05	0.000164	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GFAP—Parkinson's disease	5.27e-05	0.000163	CbGpPWpGaD
Lapatinib—ERBB4—Disease—INS—Parkinson's disease	5.26e-05	0.000163	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GRM5—Parkinson's disease	5.21e-05	0.000162	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ADRBK1—Parkinson's disease	5.19e-05	0.000161	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.06e-05	0.000157	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—DBH—Parkinson's disease	5e-05	0.000155	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—FBP1—Parkinson's disease	5e-05	0.000155	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GBA—Parkinson's disease	5e-05	0.000155	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NGF—Parkinson's disease	4.94e-05	0.000153	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—Parkinson's disease	4.91e-05	0.000152	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—FBP1—Parkinson's disease	4.88e-05	0.000151	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—DBH—Parkinson's disease	4.88e-05	0.000151	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GBA—Parkinson's disease	4.88e-05	0.000151	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NGF—Parkinson's disease	4.87e-05	0.000151	CbGpPWpGaD
Lapatinib—EGFR—Disease—ADRBK1—Parkinson's disease	4.79e-05	0.000149	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	4.78e-05	0.000148	CbGpPWpGaD
Lapatinib—EGFR—Disease—HSPA1A—Parkinson's disease	4.76e-05	0.000148	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—DDC—Parkinson's disease	4.74e-05	0.000147	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HTR2A—Parkinson's disease	4.71e-05	0.000146	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HTR2A—Parkinson's disease	4.64e-05	0.000144	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.62e-05	0.000143	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGF20—Parkinson's disease	4.56e-05	0.000142	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTA4—Parkinson's disease	4.48e-05	0.000139	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADORA2A—Parkinson's disease	4.43e-05	0.000137	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—EDN1—Parkinson's disease	4.4e-05	0.000137	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—APOE—Parkinson's disease	4.38e-05	0.000136	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	4.37e-05	0.000136	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—Parkinson's disease	4.34e-05	0.000135	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—Parkinson's disease	4.31e-05	0.000134	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—APOE—Parkinson's disease	4.31e-05	0.000134	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—Parkinson's disease	4.27e-05	0.000133	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.26e-05	0.000132	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—Parkinson's disease	4.25e-05	0.000132	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ABL1—Parkinson's disease	4.23e-05	0.000131	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—DDC—Parkinson's disease	4.11e-05	0.000128	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.09e-05	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—INSR—Parkinson's disease	4.09e-05	0.000127	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	4.03e-05	0.000125	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	4.01e-05	0.000125	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MAOB—Parkinson's disease	3.99e-05	0.000124	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HGF—Parkinson's disease	3.98e-05	0.000123	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ND3—Parkinson's disease	3.96e-05	0.000123	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.96e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—MAPK8—Parkinson's disease	3.96e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—MAPK8—Parkinson's disease	3.9e-05	0.000121	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTA4—Parkinson's disease	3.88e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGB—Parkinson's disease	3.86e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HTR2A—Parkinson's disease	3.85e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR1A—Parkinson's disease	3.84e-05	0.000119	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.83e-05	0.000119	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TAC1—Parkinson's disease	3.78e-05	0.000117	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—INS—Parkinson's disease	3.74e-05	0.000116	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—OMD—Parkinson's disease	3.73e-05	0.000116	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.73e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—DRD1—Parkinson's disease	3.71e-05	0.000115	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—INS—Parkinson's disease	3.68e-05	0.000114	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—Parkinson's disease	3.68e-05	0.000114	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—DDC—Parkinson's disease	3.67e-05	0.000114	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—DRD3—Parkinson's disease	3.59e-05	0.000112	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—DDC—Parkinson's disease	3.58e-05	0.000111	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.56e-05	0.00011	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.53e-05	0.00011	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	3.49e-05	0.000108	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTA4—Parkinson's disease	3.46e-05	0.000107	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MAOB—Parkinson's disease	3.46e-05	0.000107	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.42e-05	0.000106	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.38e-05	0.000105	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.37e-05	0.000105	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADRBK1—Parkinson's disease	3.35e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—Parkinson's disease	3.33e-05	0.000103	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.29e-05	0.000102	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MAPK8—Parkinson's disease	3.28e-05	0.000102	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR7—Parkinson's disease	3.25e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—DRD2—Parkinson's disease	3.25e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTHFR—Parkinson's disease	3.25e-05	0.000101	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.18e-05	9.86e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	3.12e-05	9.68e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MAOB—Parkinson's disease	3.09e-05	9.58e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PLA2G6—Parkinson's disease	3.04e-05	9.45e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—APOE—Parkinson's disease	3.02e-05	9.38e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MAOB—Parkinson's disease	3.01e-05	9.35e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GBA—Parkinson's disease	3e-05	9.33e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—FBP1—Parkinson's disease	3e-05	9.33e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DBH—Parkinson's disease	3e-05	9.33e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	2.97e-05	9.21e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—Parkinson's disease	2.94e-05	9.13e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.94e-05	9.12e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CTGF—Parkinson's disease	2.91e-05	9.04e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CASP3—Parkinson's disease	2.78e-05	8.64e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CASP3—Parkinson's disease	2.74e-05	8.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF2—Parkinson's disease	2.72e-05	8.45e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	2.71e-05	8.42e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NQO1—Parkinson's disease	2.68e-05	8.33e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TH—Parkinson's disease	2.64e-05	8.21e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1R—Parkinson's disease	2.63e-05	8.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—EDN1—Parkinson's disease	2.6e-05	8.07e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—INS—Parkinson's disease	2.58e-05	8.01e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	2.57e-05	7.98e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MAPK8—Parkinson's disease	2.56e-05	7.94e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYCS—Parkinson's disease	2.54e-05	7.88e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—Parkinson's disease	2.53e-05	7.84e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CTGF—Parkinson's disease	2.52e-05	7.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MAPK8—Parkinson's disease	2.52e-05	7.82e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—Parkinson's disease	2.49e-05	7.72e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NGF—Parkinson's disease	2.39e-05	7.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—Parkinson's disease	2.37e-05	7.37e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	2.35e-05	7.3e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—Parkinson's disease	2.33e-05	7.24e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NQO1—Parkinson's disease	2.32e-05	7.21e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—Parkinson's disease	2.3e-05	7.13e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	2.29e-05	7.12e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TH—Parkinson's disease	2.29e-05	7.11e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR2A—Parkinson's disease	2.28e-05	7.06e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.25e-05	6.99e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—COMT—Parkinson's disease	2.25e-05	6.98e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.24e-05	6.95e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTP1—Parkinson's disease	2.24e-05	6.95e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MAOA—Parkinson's disease	2.23e-05	6.93e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HMOX1—Parkinson's disease	2.21e-05	6.85e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DDC—Parkinson's disease	2.21e-05	6.84e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYCS—Parkinson's disease	2.2e-05	6.83e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CTGF—Parkinson's disease	2.2e-05	6.82e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ABCB1—Parkinson's disease	2.12e-05	6.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOE—Parkinson's disease	2.12e-05	6.57e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.1e-05	6.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—Parkinson's disease	2.1e-05	6.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—Parkinson's disease	2.09e-05	6.47e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.08e-05	6.46e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.07e-05	6.44e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTM1—Parkinson's disease	2.06e-05	6.38e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.05e-05	6.36e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TH—Parkinson's disease	2.04e-05	6.35e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NQO1—Parkinson's disease	2.03e-05	6.29e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TH—Parkinson's disease	2e-05	6.19e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GPX1—Parkinson's disease	1.97e-05	6.11e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.96e-05	6.09e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—COMT—Parkinson's disease	1.95e-05	6.05e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTP1—Parkinson's disease	1.94e-05	6.02e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MAOA—Parkinson's disease	1.93e-05	6e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYCS—Parkinson's disease	1.92e-05	5.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MAPK8—Parkinson's disease	1.91e-05	5.94e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HMOX1—Parkinson's disease	1.91e-05	5.93e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.88e-05	5.82e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.86e-05	5.76e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ABCB1—Parkinson's disease	1.84e-05	5.7e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—Parkinson's disease	1.82e-05	5.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—INS—Parkinson's disease	1.81e-05	5.61e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTM1—Parkinson's disease	1.78e-05	5.53e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—COMT—Parkinson's disease	1.74e-05	5.4e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.73e-05	5.37e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.73e-05	5.36e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.71e-05	5.3e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GPX1—Parkinson's disease	1.71e-05	5.3e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—COMT—Parkinson's disease	1.7e-05	5.27e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOE—Parkinson's disease	1.69e-05	5.25e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.69e-05	5.24e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MAOA—Parkinson's disease	1.69e-05	5.23e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.67e-05	5.17e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.64e-05	5.08e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—Parkinson's disease	1.63e-05	5.07e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—Parkinson's disease	1.61e-05	4.99e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.59e-05	4.94e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—Parkinson's disease	1.57e-05	4.89e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.55e-05	4.82e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.52e-05	4.73e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GPX1—Parkinson's disease	1.49e-05	4.61e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOE—Parkinson's disease	1.47e-05	4.55e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—INS—Parkinson's disease	1.45e-05	4.49e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.41e-05	4.36e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.38e-05	4.28e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.37e-05	4.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.35e-05	4.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CASP3—Parkinson's disease	1.35e-05	4.18e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—Parkinson's disease	1.34e-05	4.15e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOE—Parkinson's disease	1.31e-05	4.06e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOE—Parkinson's disease	1.28e-05	3.96e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.26e-05	3.92e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—INS—Parkinson's disease	1.25e-05	3.89e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.25e-05	3.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAPK8—Parkinson's disease	1.24e-05	3.84e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TH—Parkinson's disease	1.23e-05	3.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—Parkinson's disease	1.22e-05	3.79e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.18e-05	3.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—Parkinson's disease	1.13e-05	3.5e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—INS—Parkinson's disease	1.12e-05	3.47e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—INS—Parkinson's disease	1.09e-05	3.39e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—COMT—Parkinson's disease	1.05e-05	3.25e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.04e-05	3.23e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.04e-05	3.22e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.03e-05	3.19e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ABCB1—Parkinson's disease	9.85e-06	3.06e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTM1—Parkinson's disease	9.56e-06	2.97e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GPX1—Parkinson's disease	9.16e-06	2.84e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—Parkinson's disease	8.45e-06	2.62e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—Parkinson's disease	7.9e-06	2.45e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOE—Parkinson's disease	7.87e-06	2.44e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—INS—Parkinson's disease	6.72e-06	2.09e-05	CbGpPWpGaD
